StockNews.com Begins Coverage on Diffusion Pharmaceuticals (

StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Diffusion Pharmaceuticals stock opened at $4.40 on Friday. The firm has a 50 day moving average price of $4.64 and a […]

Related Keywords

Virginia , United States , Charlottesville , , Hedge Funds Weigh In On Diffusion Pharmaceuticals , Diffusion Pharmaceuticals Inc , Exchange Commission , Jpmorgan Chase Co , Diffusion Pharmaceuticals Trading , News Ratings For Diffusion Pharmaceuticals Daily , Diffusion Pharmaceuticals , Nasdaq , Diffusion Pharmaceuticals Company Profile , Free Report , Get Free Report , Pharmaceuticals Inc , Trans Sodium Crocetinate , Diffusion Pharmaceuticals Daily , Nasdaq Dffn , Dffn , Medical , Initiated Coverage , Stocknews Com ,